The TauTona Group

What is The TauTona Group?

The TauTona Group is a vertically-integrated operational fund with a primary focus on creating, investing in, and developing new solutions geared towards the medtech, biotech, and regenerative medicine sectors. Their goal is to address the unmet clinical needs within the healthcare industry. They operate with a strong conviction that essential improvements in healthcare outcomes and cost reductions are accomplished through consistent innovation.

TauTona's investment model is designed to be sustainable, allowing for disruptive ideas to be evaluated, designed, tested, and developed in a cost-effective manner, which benefits all stakeholders involved, ranging from inventors and investors to doctors, and most crucially, patients.

Founded in 2010 by two professors from Stanford School of Medicine, with a background in bioengineering, tissue regeneration, and stem cell therapeutic approaches, TauTona has established a reputable presence in their field.

The team is composed of world-class professionals including doctors, researchers, engineers, and entrepreneurs, who collectively boast a track record of building several companies and medical devices.

TauTona takes pride in their valuable pipeline of cutting-edge products that have the potential to enhance research and development and optimize portfolios for leading healthcare companies. Their differentiated development process is specifically designed to de-risk projects from the ideation phase all the way to commercialization, ensuring the maximization of medical impact as well as financial returns. The fund's philosophy embraces a contrarian approach, setting the stage as an ideal investment platform to accelerate the development of medical devices.

TauTona Group has created several innovative medical devices including the Pneumoperitoneum Assist Device (TPAD), BioBolt Surgical Stapler, and TauTona Wound Dressing (TWD), each reflecting the group's commitment to advancing the human condition. They have also been featured in news for their acquisitions by companies such as Allergan, LifeCell, and Novadaq.